PhoenixBio Co (TSE:6190) Cyclically Adjusted Book per Share: 円490.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6190 PhoenixBio Co Ltd TSE:6190
51 GF Score
Price 円348.00
GF Value 円354.02
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Cyclically Adjusted Book per Share?

PhoenixBio Co TSE:6190 +1.46% 51 Cyclically Adjusted Book per Share is 円490.16 as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 51/100 and a GF Value™ of 円354.02 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PhoenixBio Co's adjusted book value per share for the three months ended in Mar. 2026 was 円381.481. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円490.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PhoenixBio Co's average Cyclically Adjusted Book Growth Rate was -6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-08), PhoenixBio Co's current stock price is 円348.00. PhoenixBio Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円490.16. PhoenixBio Co's Cyclically Adjusted PB Ratio of today is 0.71.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of PhoenixBio Co was 1.19. The lowest was 0.60. And the median was 0.86.


PhoenixBio Co  (TSE:6190) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PhoenixBio Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=348.00/490.16
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of PhoenixBio Co was 1.19. The lowest was 0.60. And the median was 0.86.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PhoenixBio Co Cyclically Adjusted Book per Share Related Terms


PhoenixBio Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Cyclically Adjusted Book per Share Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 512.39 523.22 490.16

PhoenixBio Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 523.22 0.00 0.00 0.00 490.16

TSE:6190 vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, PhoenixBio Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Cyclically Adjusted PB Ratio falls into.


TSE:6190
51GF Score
PhoenixBio Co Ltd TSE:6190
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhoenixBio Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=381.481/112.7000*112.7000
=381.481

Current CPI (Mar. 2026) = 112.7000.

PhoenixBio Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 684.012 97.900 787.417
201606 666.173 98.100 765.318
201609 668.422 98.000 768.685
201612 709.006 98.400 812.042
201703 728.456 98.100 836.870
201706 680.599 98.500 778.716
201709 659.034 98.800 751.752
201712 656.871 99.400 744.762
201803 639.153 99.200 726.135
201806 581.141 99.200 660.228
201809 554.780 99.900 625.863
201812 553.692 99.700 625.889
201903 527.765 99.700 596.581
201906 501.836 99.800 566.703
201909 476.877 100.100 536.903
201912 465.683 100.500 522.214
202003 395.994 100.300 444.950
202006 390.200 99.900 440.196
202009 325.376 99.900 367.066
202012 298.199 99.300 338.439
202103 332.722 99.900 375.353
202106 381.753 99.500 432.398
202109 327.311 100.100 368.511
202112 317.028 100.100 356.934
202203 250.424 101.100 279.157
202206 285.754 101.800 316.350
202209 370.505 103.100 405.004
202212 392.333 104.100 424.745
202303 416.751 104.400 449.884
202306 440.095 105.200 471.471
202309 439.423 106.200 466.318
202312 440.435 106.800 464.766
202403 446.278 107.200 469.175
202406 456.813 108.200 475.812
202409 416.078 108.900 430.597
202503 337.137 111.100 341.992
202506 339.127 111.700 342.163
202509 339.427 112.000 341.548
202512 373.343 113.000 372.352
202603 381.481 112.700 381.481

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円490.16 mean?
PhoenixBio Co (TSE:6190) has a Cyclically Adjusted Book per Share of 円490.16 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PhoenixBio Co and its competitors.
Is PhoenixBio Co's Cyclically Adjusted Book per Share too high?
PhoenixBio Co's current Cyclically Adjusted Book per Share is 円490.16. Overall, PhoenixBio Co has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
PhoenixBio Co's Cyclically Adjusted Book per Share of 円490.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current Cyclically Adjusted Book per Share is 円490.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円354.02, compared to a current price of 円348.00 — trading 1.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円490.16. PhoenixBio Co's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Cyclically Adjusted Book per Share is 円490.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円348.00 is trading 1.7% below its estimated GF Value™ of 円354.02. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • Cyclically Adjusted Book per Share: 円490.16
  • GF Value™: 円354.02 vs. price of 円348.00 (1.7% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
51GF Score

Get the complete analysis for TSE:6190

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円348.00
Price
円354.02
GF Value